Corebridge Financial’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-85,878	Closed	-$119K	–	2592
2025 Q1	$119K	Sell	85,878 -1,272	-1%	-$1.77K	﹤0.01%	2355
2024 Q4	$151K	Sell	87,150 -4,948	-5%	-$8.56K	﹤0.01%	2336
2024 Q3	$185K	Buy	92,098 +6,040	+7%	+$12.1K	﹤0.01%	2267
2024 Q2	$194K	Buy	+86,058	New	+$194K	﹤0.01%	2216